RE: Surescripts survey finds that more than half of of patients have experienced delays or disruption in getting their prescriptions…
Morning Headlines 5/3/19
Allscripts announces first quarter 2019 results
Allscripts announces Q1 results: revenue flat, adjusted EPS $0.16 vs. $0.15, beating on earnings but falling short of revenue expectations.
CirrusMD raises $15 million in a Series B funding round, and announces that its chat-based telemedicine software will be implemented at three VA medical centers.
UBiome places its co-CEOs on administrative leave as the company deals with fallout from an FBI raid and highly questionable business practices that included pressuring doctors to approve its tests and billing payers multiple times without patient consent.

Her?